RAP 0.00% 20.5¢ resapp health limited

Ann: RAP Licenses Additional Pneumonia Diagnostic from UniQuest, page-65

  1. 2,574 Posts.
    lightbulb Created with Sketch. 4962
    Lol it's just an extra function (tool) that works in areas were smartphones are not accessible so whoever has a smartphone can use option A ResAppdx software. Whoever doesn't have a smart phone can use the dumb phone (option B) so ultimately this broadens our market penetration and gives the consumer more options to be assessed by a physician without having to go into a doctors office or Hospital.

    1. More lives saved
    2. Broader market penetration
    3. More leverage for other deals
    4. More money in RAP's pocket
    5. Higher share price potential
    6. Future larger takeover/dividend payments coming our way

    What's not to like or understand about this extra algorithm---its BLOODY AWESOME!!

    Looking forward to a management app coming soon....

    Counting down the days on my hands now I reckon to reach 1500 patients...

    Exciting times! What an honour to be part of this company...

    Cheers

    Red bar
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.